Schedule 13G ownership disclosure

Whitehawk Therapeutics, Inc.

Common Stock, par value $0.0001 per share · CUSIP: 00032Q104

Event date: 2024-12-31

Filing-level shares
659
Percent of class
0%
  • Satter Muneer A

    Shares: 659 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895345-25-000071
Form type
SCHEDULE 13G/A
Filer
Whitehawk Therapeutics, Inc.
CIK
CIK 1422142
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub